Clinical Trial Update: Effectiveness Study of Pramlintide to Treat Post-Transplant Diabetes Mellitus [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating pramlintide for post-transplant diabetes mellitus has been withdrawn, with no reported results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Post-transplant Diabetes Mellitus

Drugs mentioned

• Symlin (pramlintide)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Diabetes Mellitus | Phase 1, Phase 2 | Status: WITHDRAWN